Research synthesisModerate evidenceModerate effect3 studies · 3 beneficial · 0 neutral · 0 harmful
Across all 3 available studies, raspberry-derived ellagic acid showed consistent moderate beneficial effects on reducing triglyceride levels, with statistically significant reductions observed in each trial. The most studied dose range is 180–200 mg/day of ellagic acid, and effects were typically observed over 8 weeks (median 56 days). Populations included individuals with metabolic dysfunction-associated steatotic liver disease (MASLD), non-alcoholic fatty liver disease (NAFLD), and metabolic syndrome.
- Effective dose range: 180–200 mg/day of ellagic acid
- Studied populations: people with metabolic dysfunction-associated steatotic liver disease (MASLD), non-alcoholic fatty liver disease (NAFLD), or metabolic syndrome
Caveats: Evidence base is small (only 3 studies) — conclusions should be considered preliminary. Available evidence is overwhelmingly positive, but clinical literature in this area is subject to publication bias. Importantly, all studies used ellagic acid (a compound found in raspberries) as the intervention, not whole raspberry or raspberry extracts — effects may not generalize to dietary consumption of the fruit.
Generated Jun 14, 2026